Christmas is over, yesterday’s news. And the mass retailing community is scampering to assess its impact on sales, earnings and the future. For chain drug retailers, this holiday selling season, like so many before it, was acceptable, if hardly record-setting.
Executive Summary: The Winds of Change Are Blowing The CPG Industry Is Still Struggling to Find Growth: Across CPG channels and aisles, growth is still proving hard to come by even several years after the end of the Great Recession.
Rite Aid Corp. posted flat retail pharmacy sales results for December, despite an uptick in same-store sales at the front end. The drug chain said Thursday that for the four weeks ended Dec. 26, same-store sales dipped 0.1% year over year. That compared with comparable-store sales growth of 0.
Drug chains were not immune to the shift in holiday shopping away from brick-and-mortar retailing. Holiday retail sales growth barely exceeded 4%, down from last season’s 4.4% advance and well off the 5.
Pharmacists rank high in terms of public trust, but they fall short of being No. 1. Nurses topped Gallup’s Honesty and Ethics of Professions rankings for 2015, a feat that the profession has accomplished every year but one since it was added to the list in 1999. The exception is 2001, when
Glenmark Pharmaceuticals Inc. USA has been granted approval from the Food and Drug Administration for linezolid tablets 600 mg, an antibiotic. Glenmark said its linezolid product is a therapeutic equivalent of Zyvox tablets 600 mg from Pfizer Inc.
A bipartisan coalition of congressmen is urging the participation of retail pharmacists in a new initiative to improve the use of medication therapy management (MTM) in Medicare. The National Association of Chain Drug Stores said Wednesday that 44 members of the U.S.
Aurobindo Pharma Ltd. has received approval from the Food and Drug Administration for olopatadine hydrochloride ophthalmic solution 0.1%. Aurobindo said its olopatadine HCl ophthalmic solution product is a generic version of Patanol ophthalmic solution/drops from Alcon, a Novartis company.
The Food and Drug Administration has established the Office of Dietary Supplement Programs (ODSP), raising the program from its previous status as a division under the Office of Nutrition Labeling and Dietary Supplements.
Coty Inc. has named Andraea Dawson-Shepherd as senior vice president of corporate affairs, a newly created position. The beauty care company said late Friday that in the role Dawson-Shepherd will lead Coty’s communication and corporate affairs agenda as it continues its expansion and transformation.
Both patients and pharmacists give high marks to medication synchronization programs, according to a recent survey by the National Community Pharmacists Association.
Walgreens Boots Alliance (WBA) Inc. has completed $12.8 billion in term loan facilities as part of the financing for its $17.2 billion deal to acquire Rite Aid Corp. WBA said Monday that the transactions include the placement of $5 billion of term loan facilities — split between two tranches of $2.
Longtime retail consultant/analyst Walter Loeb likes what he sees from CVS Health. In a Forbes article on Friday, Loeb described CVS as a compelling health and wellness destination, especially in the wake of its acquisition of Target Corp.
Tony Rogers reportedly has been appointed as chief marketing officer at Walmart. Published reports said Friday that Rogers, a 10-year company veteran who has been CMO of Walmart China for the past two years, succeeds Stephen Quinn, who is retiring.
Eli Lilly and Co. and Boehringer Ingelheim Pharmaceuticals Inc. have received approval for Basaglar long-acting insulin (insulin glargine injection, 100 units/ml) in the United States.
Merck has received approval from the Food and Drug Administration for an expanded age indication for Gardasil 9, its 9-valent human papillomavirus (HPV) vaccine.
